Type 1 Diabetes News

New technology that allows diagnosis of diabetes and treatment of diabetic retinopathy just by wearing 'Smart Light-emitting diode (LED) Contact Lens.' Contact lens that tests blood sugar levels.

A new study soon to be published in the Journal of Pediatrics explores the effectiveness of telemedicine in helping school nurses and children manage diabetes care.

A new discovery may lead to the recovery of insulin-producing beta cells in people with type 1 diabetes. A Yale-led research team identified how insulin-producing...

The discovery of a gene believed to be connected to morbid obesity has international origins and began as an exploration into the causes of Type I diabetes.

A bionic pancreas system developed for home use reduced average blood glucose levels while decreasing the risk of low blood sugar - and it's...

GenStrips are advertised for use with the LifeScan OneTouch family of glucose meters. The affected test strips have been manufactured and distributed since March 2013 and are available through online retailers and retail pharmacies.

A new, minimally invasive transplant technique has restored natural insulin production in a woman with Type 1 Diabetes. She is now completely off insulin...

A new study published in the Journal of Nutrition Education and Behavior found that many cooking TV shows fail to model proper food safety...

New research suggests that germs may be partly to blame for the development of type 1 diabetes because they activate killer T-cells. Germs could play...

Scientists have examined in unprecedented detail the immune cells long thought to be responsible for type 1 diabetes. They caught the immune cells, known as dendritic cells, "red-handed": they were carrying insulin and fragments of insulin-producing cells.

Medtronic has started a worldwide recall of specific lots of infusion sets used with all models of Medtronic insulin pumps for diabetes due to hypoglycemia risk.

At extremely high blood glucose levels (1024 mg/dL and above), the OneTouch Verio IQ Meter will not provide a warning and will shut off

Researchers at Johns Hopkins have found a way to overcome a major stumbling block to developing successful insulin-cell transplants for people with type I diabetes.

The landmark Diabetes Control and Complications Trial showed conclusively that tight blood glucose control significantly reduces the risk of developing complications of diabetes such as eye, kidney and nerve disease. But the DCCT also showed that tight control -- achieved by taking three or more insulin injections daily -- can come at a cost.

Testosterone deficiency, previously recognized as common in men with type 2 diabetes, is also common in men with type 1 diabetes according to a new study.

Type 1 diabetics who have developed low blood sugar (hypoglycemia) as a complication of insulin treatments over time are able to regain normal internal recognition of the condition after receiving pancreatic islet cell transplantation.